Atlas Trials

The Effectiveness of Urine mtDNA and Beta 2-MG to Predict Acute Kidney Injury for Critically Ill Surgical Patients

Clinical trial NCT05458063 · COMPLETED

Trial details

NCT number
NCT05458063
Sponsor
Wonju Severance Christian Hospital
Status
COMPLETED
Study type
OBSERVATIONAL
Surgery-ComplicationsAcute Kidney InjuryCritical Illness
Start date
2022-07-25
Primary completion
2024-06-10
Enrollment
113

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.